To investigate the relevance of these findings in AML, we isolated primary leukemia cells from the peripheral blood of AML patients carrying wt-IDH2 or mutant IDH2 (Additional file 1: Table S1) and treated the leukemia cells with DM-αKG. This evidence concerns the gene IDH2 and leukemia.